TENTANG EPISODE INI
Are you making the most of immune checkpoint inhibitors in advanced gynecologic cancers?
Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/precision-practice-optimizing-immunotherapy-recurrent-2026a1000zys?ecd=bdc_podcast_libsyn_mscpedu
Inggris
Amerika Serikat
TRANSKRIP 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CARI EPISODE TERDAHULU
Cari episode sebelumnya dari Keeping Current CME.
EPISODE LAIN DALAM PODCAST INI
Experts discuss recent clinical guidelines and trial data on JAK inhibitors for systemic lupus erythematosus (SLE) treatment.
Credit available for this activity expires: 10/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/next-frontier-sle-management…
Where do oral obesity medications fit alongside injectables, and how can you match the right option to the right patient?
Credit available for this activity expires: 10/09/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-injectables-where-do-ora…
Experts discuss the latest efficacy and safety data on systemic treatments for prurigo nodularis.
Credit available for this activity expires: 10/12/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/itch-insight-prurigo-nodularis-countdown-2026a10010t5…
Experts discuss new clinical trial data and long-term safety of Janus kinase (JAK) inhibitors in alopecia areata (AA).
Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pathway-prescription-alopecia-areata…
Sanggahan: Podcast dan karya seni yang disematkan pada halaman ini berasal dari Medscape, yang merupakan milik pemiliknya dan tidak berafiliasi atau didukung oleh Listen Notes, Inc.
Sunting
Terima kasih telah membantu agar basis data podcast tetap terbaru
